To focus our efforts and increase our impact, we have designed two umbrella focus areas under the themes Improved Patient Outcomes and Science of Prevention and Detection.
Rising Tide Foundation for Clinical Cancer Research (RTFCCR) is a charitable, non-profit organization established in 2010.
Our primary consideration in granting support is given to truly innovative, unique, patient-centered clinical research that has the potential to positively impact the lives of cancer patients at the earliest opportunity. We provide funding for research that directly benefits patients. We do not provide funding for basic research.
Funding can be provided to any relevant institution in any country where meaningful grant oversight is possible.
Using a patient centered approach, we support research grants that enable patients to better understand their treatment options and to have a voice in trial design, thereby empowering them to be active agents in enhancing their quality of life.
We embrace the pivotal role that patients play in developing approaches for the diagnosis and management of cancer and its effect on everyday life. We involve patients by putting their experiences to use, helping to shape research so that it is carried out with or by patients, rather than to or for them.
Researchers should involve patient representatives, such as experts or advocates, to help improve methodology and research outcomes. This increases the credibility of the results while acknowledging the fact that patients should have a say in health care and health research when it is expected that decisions in these areas impact them.
The strategy, modalities, and budgets for patient involvement, related deliverables, and expected outcomes must be clearly described in the grant application. For more information on how to involve patients in research, please refer to the following resources:
To highlight our sense of urgency, we expect that clinical research projects should result in patient impact within 5 years and are expected to start within 6 months of approval unless otherwise agreed.
We are one of several players in this area, and we share objectives with a broad range organizations worldwide. We partner with them in order to leverage resources to accelerate the improvement of patient treatment options and quality of life everywhere.